tirzepatide with lysine a novel anti diabetic molecule unfold dual action | Discover Public Health CID 163285897 | C225H348N48O68 |

Many of our peptide patients run both protocols simultaneously

Whoever owns the patient relationship in this space at scale wins

PlexusDx takes a precision-wellness approach by combining compounded GLP-1 options with optional genetic testing to support personalized conversations with qualified healthcare providers

Chakraborty, A

Metabolic markers HbA1c, lipids, kidney markers, and liver enzymes give useful context when GLP-1 therapy and supplements affect appetite, hydration, or blood sugar

Thats not all - research in the International Journal of Cosmetic Science found that its active compound, berberine, may help reduce fat accumulation and slow down fat cell development